“Watching my mentor and advisor, who had a significant impact on my personal and professional life by his unconditional support, succumb to cancer left me frustrated with the state of oncology imaging. I focused my attention on this problem with my Chemistry PhD Dissertation which was the foundation for TheraCea” - Iman Daryaei, Chief Scientific Officer, Co-Founder
Meet the Team
“It's a privilege to head a group of very talented people who share the goal of finding next-generation radiolabeling and detection technologies for cancer and neurological disorders. Turning an idea into reality is never easy. I’m fortunate to have amazing scientific advisors, an experienced board and an operation team focused on making TheraCea a success.” - Iman Daryaei, Chief Scientific Officer, Co-Founder
Board
Iman Daryaei, PhD - CEO / CTO / Co-Founder
Dr. Iman Daryaei is a co-founder and co-inventor of TheraCea Pharma's fundamental technology. He has over 15 years of academic and industrial experience in the medicinal and radiopharmaceutical domain. During the last four years, TheraCea has received considerable non-dilutive funding under his leadership.
Patricia Beckmann, PhD
Experienced entrepreneurial bioscience and business advisor. Co-inventor of Enbrel (worldwides sales >$6B). Venture Capitalist and Angel Investor.
Mike Sember, MBA
Over 30 years of C-Level experience in the pharmaceutical and medical device industries. Angel Investor active in multiple groups.
Scientific Advisors
Mark Pagel, PhD
Co-inventor of TheraCea’s initial technology. Principal Researcher at MD Anderson Cancer Center, Houston, TX.
Jean-Luc Vanderheyden, PhD
30 years of experience in the nuclear medicine industry
Alisa Tubbs, MBA
Alisa Tubbs has led the development of over 30 diagnostic products for research and clinical use, and brings a breadth of corporate strategy, marketing and industry partnership experience to the TheraCea team.
Justin Jeffery, MBA - Co-Founder
Justin is a serial entrepreneur with 14 years of experience in managing imaging facilities and instrumentation. He is the co-founder of TheraCea Pharma.
Operations
Iman Daryaei, PhD
Dr. Iman Daryaei is a co-founder and co-inventor of TheraCea Pharma's fundamental technology. He has over 15 years of academic and industrial experience in the medicinal and radiopharmaceutical fields. During the last four years, TheraCea has received considerable non-dilutive funding under his leadership.
Scott Zentack, MBA, CFA - President of Operations and Strategy
Scott is addressing the business challenges associated with developing and commercializing TheraCea's breakthrough technologies, drawing on his experience in Finance, Operations, Sales & Marketing, and Engineering, as well as his co-founding of a bioscience company.
Ed Marinelli, PhD - VP of Research and Development
With over 35 years of professional experience, Dr. Marinelli specializes in developing contrast agents for various imaging modalities. He holds over 40 granted US and international patents and has directly contributed to five successful diagnostic/therapeutic products in clinical trials.
Julian Dresler - Director of Research & Development
Julian Dresler started his role in TheraCea as a summer intern to work on a chemistry project. His talent and knowledge in chemistry led him to become TheraCea’s Laboratory Manager at the end of his internship. Julian’s leadership capacities combined with his technical expertise promoted him to serve as a Manager of R&D.
Nathan Wright, MSC - Director of Operations
Nathan Wright obtained his official training in disease physiology. He has led TheraCea in several internationally recognized entrepreneurship programs, and has been a core member of TheraCea since inception.
Zachary Brooks, PhD - Director of Business Development
Zachary Brooks, PhD has helped raise $4.4M in five startup companies. For TheraCea, Zach engages with next generation partners for TheraCea growth.